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It has been postulated that ultraviolet radiation (UVR) 
alters antigen presentation by macrophages. This is 
thought to be due, in part, to inhibition of macrophage-
derived interleukin 1 (IL-l), which is a hormone-like 
factor with immunoregulatory functions. Conventional 
stimulator cells for antigen presentation are macro-
phages; however, other cell types such as epidermal 
Langerhans cells are capable of antigen presentation. 
Keratinocytes also play a role in the immune system by 
providing a factor with IL-l-like activity, termed Epider-
mal cell-derived Thymocyte-Activating Factor (ETAF). 
The purpose of this study was to determine whether 
UVR affects alloantigen presentation by epidermal cells 
and if so, whether the UV-induced change is due to UVR 
alteration in ETAF activity . Epidermal cells from UV-
treated BALB/c mice (UV-EC) or from non-UV-treated 
mice (EC) were x -irradiated and then cocultured for 5 
days with a llogeneic T cells from C57Bl/6 mice. UV-EC 
caused less T-cell stimulation than did EC from non-UV-
treated animals. When chromatography purified frac-
tions of ETAF were added to cultured UV-EC, partial 
restoration ofT-cell stimulation was seen. These results 
suggest that this UV-induced defect in alloantigen 
presentation is due, in part, to decreased ETAF activity. 
The mixed lymphocyte reaction involves the interaction ofT 
cells (responder cells) with !-region determinants of allogeneic 
cells (stimulator cells). Macrophages [l-4), and, in particular, 
!a-bearing macrophages, are considered to be the major stim-
ulatory cells in a mixed lymphocyte reaction [5-7). The mixed 
lymphocyte reaction has been used for studying the basic 
mechanisms of alloantigen recogni tion. It can be considered an 
in vitro correlate of the graft-vs.- host reaction [8) and a llograft · 
rejection [9], and is especially useful in selecting the best donor-
recipient combination when several potential donors are avail-
able for organ transplantation. It has been demonstrated that 
apposition between macrophages and T cells is req uired for 
allogeneic T-cell stimulation [10], and recent studies suggest 
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Abbreviations: 
ala + C': anti-la antiserum plus complement 
EC: epidermal cells from non-UV-treated mice 
ELR: epidermal lymphocyte reaction 
ETAF: epidermal cell-derived thymocyte-activating factor 
FCS: fetal calf serum 
IL-l: interleukin 1 
2-ME: 2-mercaptoethanol 
NMS + C': normal mouse serum plus complement 
PHA: phytohemagglutinin 
PMA: phorbol myristic acetate 
UV-EC: epidermal cells from UV-treated mice 
UVR: ultraviolet radiation 
that hormone-like antigen nonspecific factors are required to 
augment the reactivity of responder T lymphocytes for optimal 
T-cell stimulation [11-14]. It appears that a helper T cell must 
receive two types of signals in order to r espond to soluble 
antigen [12,15]. First, the T ceil recognizes antigen in association 
with Ia antigens on the surface of the macrophage. The second 
signal is provided by a nonspecific helper factor produced by 
the macrophage [15]. It has been postulated that this soluble 
helper factor is interleukin-1 (IL-l) [16). 
Laffer ty and Woolnough have shown that ultraviolet radia-
tion (UVR) can destroy the ability of cells to act as stimulators 
in the mixed lymphocyte reaction [12] and they have suggested 
that this defect was due to an alteration in the solu ble second 
signal. More recently, Germain has demonstrated that UV-
induced inhibition of antigen presentation (UVR given after 
antigen pulsing) could be restored with phorbol myristic acetate 
(PMA), which stimulates IL-l production [17]. 
In addition to the conventional stimulator cells used for 
antigen presentation, namely macrophages, epidermal Langer-
hans cells, are also capable of antigen presentation [18-20]. 
Langerhans cells are the only epidermal cells capable of this 
function . Keratinocytes also play a role in the immune response 
by producing a factor that is biochemically and functionally 
similar to IL-L This factor has been termed Epidermal cell-
derived Thymocyte-Activating Factor (ETAF) [21). In addi-
tion, ET AF is produced by the spontaneously transformed 
keratinocyte cell line Pam 212 [22). 
In contrast to macrophages, which reside in tissues not nor-
mally exposed to UVR, Langerhans cells reside in the epidermis 
which is constantly exposed to UVR. Since we, as well as others, 
have shown that UVR can alter antigen presentation by mmine 
epidermal cells [23,24], we sought to determine whether UVR 
would alter alloantigen presentation by epidermal cells and 
whether this was related to alteration in ET AF activity. T he 
results of this study show that UVR can inhibit alloantigen 
presentation by epidermal cells and that this alteration is 
associated with decreased ETAF activity. In addition, supple-
mentation by exogenous ET AF is capable of partially reversing 
the defect in antigen presentation. 
MATERIALS AND METHODS 
Mice 
Specific-pathogen-free female mice of BALB/ c AnN strain were 
supplied by the Animal Production Area of the Frederick Cancer 
Research Facility (Frederick, Maryland) . The mice were 8-12 weeks 
old. C57Bl/6 mice were obtained from Jackson Laboratories (Bar 
Harbour, Maine) and were 12-16 weeks old when used. C3H/ HeJ mice 
were obtained from Jackson Laboratories and were 8-12 weeks old. 
UVR Treatment of Mice 
A 2.5-kW xenon arc was used as the light source, coupled to UV 
interference fil ters (Corion Corp., Waltham, Mas achusetts) , of peak 
transmission at 270 nm as previously described [25]. An area of irradia-
tion of 50-60 cm2 was produced, allowing for the total dorsal irradiation 
of 3 mice simultaneously. The dose delivered was 175 J / m2 . Irradiance 
measurements were made using an International Light Radiometer 
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(model 700) coupled to a UVB detector (#PT171C) containing a WB320 
interference fi lte r with a cosine correcting diffuser. Nine measurements 
were taken across the field before and afte r each exposure. The average 
was used to calculate the dose. Additional measurements were made 
using an Optronics Spectroradiometer (Model 742, Optron ics Labora-
tories, Orlando, F lorida) . Irradiances were in agreement to within 10%. 
The hair was removed from the back skin of the mice (approximately 
10 cm2 ) by plucking, immediately before irradiation. The mice were 
placed in a quartz-covered lucite conta iner (11.5 em diameter X 5 em 
depth) which had air holes in the sides and 3 individual compartments. 
Control mice, epilated as above, were placed in an identical conta iner 
kept in the da1·k for the same period of time as the UV irrad iation. 
Both contro l and UV containers were set atop turn tables ro tating at 3 
rpm. Exposure t imes were under 2 h. Immediate ly following treatment, 
mice were returned to thei1· convent ional cages. The wavelength of 270 
nm was chosen since we wanted to avoid a lte ring the morphology of 
Langerhans cells which occurs at doses greater than 100 J / m2 [26). In 
addition, narrow-band radiation of this energy caused no gross a ltera-
tion in the epide rmis and no inflammatory infil trate was seen. 
Culture Medium 
RPM! 1.640 conta ining 100 uni ts/ml penicillin and 100 1-'g/ml strep-
tomycin (M icrobiological Associates, Walkersville, Maryland) supple-
mented with 1.0% heat- inac tivated fetal calf serum (FCS, Microbiolog-
ical Associates) 5 x 10- '• M 2-mercaptoethanol, and 2 mM glu tamine 
(G rand Is land Biological Company, Grand Is land , New York) was used . 
Epidermal Cell Suspension. 
Animals were sacrificed and back skin was obtained 24 h afte r UV 
irradiation. Epide rmal ce lls were prepared by trypsinization of whole 
skin (only treated area or control area of back skin was used) as 
previously desc ribed [21]. The bulk of the epidermal ce lls are keratin-
ocytes; the remaining cells are Langerhans cells (approximately 2-5%) 
and melanocytes (approximately 5%). 
Responder T Cell Preparation. 
Spleens from fema le C57BI/6 mice (12-16 weeks old) were disrupted 
with a syringe and forceps. A cell suspension was obtained and washed 
3 t imes in RPM! 1640 (GIBCO, Grand Island , New York) supplemented 
with 10% heat- inactivated FCS (GIBCO) . In order to obta in a purified 
T -cell population depleted of !a-beaTing macrophages and B cells, t he 
spleen ce lls· were treated with a 1:10 dilu t ion of polyspecific ant i-Ia 
antiserum (A.TH anti A.TL) plus a 1:10 dilu tion of guinea pig comple-
ment (GIBCO) for 30 min at 37°C and then passed over a nylon wool 
column. T hus, in order to achieve T-cell stimulation in this system, 
epidermal cells would have to serve both as stimulator ce lls and as 
accessory cells. Nonadherent ce lls were then washed 3 times and 
incubated for 30 min at 37°C in a plastic Petri dish (Falcon, Oxnard, 
California). The nonadherent population contained more than 90% T 
ce lls as determined by anti-theta staining. T he puTitled T-ce ll popula-
tion was then washed and adjusted to 2 x JO" viab le cells/mi. 
Allogeneic Epidermal Cell Lymphocyte Reaction (ELR) 
Epidermal cells (2 X 10°, 1 x 10'', or 0.5 X 10'') from UV- oT non-UV-
treated BALB/c mice were treated with 2000 rads x-ray, then incubated 
with 2 X 10'' C57BI/6 T cells in round-bottom plates (Dynatech Labo-
ratories Inc., Alexandl'ia, ViTginia). Wells with T cells a lone were used 
to determ ine background coun ts. Cells were cultured for 1-14 days at 
37°C with 5% 0 2 in humidified a ir. S ixteen hours before termination 
of the cultures, 0.5 ,..c i tri tiated thym idine (["HlTdR 1.9 Ci/ mm, New 
England Nuclear, Boston, Massachusetts) was added. Cells were col-
lec ted on fil te r paper with the a id of a Mash II harvester (Microbiolog-
ical Associates) and the "H activity on the fil ter discs was counted in a 
sc intillation coun ter. The resul ts a re expressed as the mean cpm 
["HlTdR incorporation ± SE of triplicate cultures. 
Assessment of ETAF Activity from UV- a.nd Non -UV-Treated 
Anim als 
Epidermal cell suspensions were prepared from (175 J / m") UV- and 
non-UV-t rea ted mice. Viab le ce lls (2 X 10';/ ml ) were cul tured for 3 days 
in H.PMll640 supplemented as before. The ce ll-free supernatants were 
dialyzed overnight against 50 volumes of RPM I 1640 and then sterilized 
by Millipore filtration (M illipore Corp ., Bedford , Massachusetts). These 
supernatants were then tested for ETAF ac tivity us ing lhe thymocyte 
proliferation assay [21]. Briefl y, l.5 X 10~; C3H/HeJ thymocytes were 
cultured for 72 h in Costar fl at-bottom plates (Co tar, Cambridge, 
Massachusetts) in 200 fll of H.PMI 1()40 wilh 10% FCS, penicillin, 
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streptomycin, glu tamine, 2-mercaptoethanol (2-ME) , 1 1-'g/ml phyto-
hemagglu tinin (PHA), and varying dilutions of the supernatants. Cul-
tures were pulsed with 0.5 ,..c i ["H]TdH. for the final 16 h. 
Preparation. of Semipurified ETAF 
Epiderma l ce lls fwm non-UV-treated mice were cul tured for 3 days 
as described above. Supernatants were then concentrated 30x using 
Amicon ul trafil tration cells with PM-10 Diaflo membranes (Amicon 
Corporation, Lexington, Massachusetts). Three millili ters of the con-
centrate were then placed on a Sephadex G-50 superfine column using 
reverse flow. A fl ow rate of 7 ml/h was used and 3.5- ml fract ions were 
collected. Aliquots of these fractions were di lu ted 1:4 in HPMI 1640, 
fil ter sterilized, and tested for ETAF activity in the thymocyte prolif-
eration assay . When tested in this way, the ETAF preparations used 
yielded approximate ly 15,000 cpm ["H]TdR incorporation in the thy-
mocyte as ay compru·ed to background of 500 cpm. The active fractions 
were then obtained (approximate M,. 12,000). 
A utologous Epidermal Cell Lymphocyte R eaction 
Epidermal cells (2 X 10", l X 10'', or 0.5 X 10'') from UV -treated or 
non-UV-treated C57BI/6 mice were treated with 2000 rads x-ray, then 
incubated with 2 X 10° C57BI/ 6 T cells in round-bottom plates (Dy-
natech) . Wells with T ce lls a lone were used to determine background 
counts. Cells were cultured 5 days at 37°C with 5% CO~ in humidified 
air with or without the addition of ETAF, then pulsed with ["H]TdR, 
harvested, and coun ted as stated for a ll ogeneic ELR The results ru·e 
expressed as the mean cpm [''H]Td R incorporated ± SE of t riplicate 
cul tures. 
Addition of ETAF to Epidermal Lymphocyte Cultures 
Fifty micro li te rs of Sephadex G-50 puri!ied fractions containing 
ETAF activity were added to 150 ,..1 of cul tures (final dilu t ion 1:4) 
containing responder T ce lls and epidermal cells from UV-treated mice 
or non-UV-treated mice. Epidermal lymphocyte cultures were then 
mainta ined as before and assessed for a lloantigen-presenting abili ty. In 
order to determine whether the ETAF preparation used was increasing 
the stimulatory ab ili ty of epidermal ce lls, ETAF was added to epidermal 
lymphocyte cultures conta ining epidermal ce lls from UV- and non-UV-
treated recipients. In addi tion, ETAF was added to autologous epider-
mal lymph ocyte cul tures. 
Depletion of Langerhan.s Cell:; from Epidermal Cell Suspensions 
Since Langerhans cells ru·e the only epidermal cells that bear surface 
Ia [18], epidermal cell suspensions were depleted of Langerhans cells 
by treating with anti-la ant iserum plus complement as described pre-
viously [21]. Normal mouse serum plus complement was used as a 
control. The depleted popula tion contained less than 0.1% Langer hans 
ce lls as compared to 1.8% in the control group. 
Assessment of Viability a.(ter UVR Treatment 
In order to determine whether UVH indu ced selective a lterations in 
Langerhans cell viab ili ty, epidermal ce lls from UV- or non-UV-treated 
mice were cultured as described above. Viability was assessed by trypan 
blue dye exclusion on day 0 to day 5. In addi tion, the percentage of 
viable cells that were !a-positive was determined using a modification 
of the double staining technique of van Hood et a l [27], as previously 
described [23]. B riefly, Langerhans cells were stained with polyspecific 
Ia ant iserum (A.TH ant i A.TL) which reacts with Ia of most haplotypes 
includ ing l a11 , us ing a flu orescent 2-step procedure, and cell viability 
was assessed by the ab ili ty to excl ude ethidium bromide. 
Statistical A nalysis 
Student's /.-test was used to assess differences between UV- and non-
UV-treated groups. Each experiment was performed at least twice, 
except for the ti me course which was performed once. Representative 
results ar e presented. P values of less than 0.05 were considered 
significant. 
RESULTS 
Time Cou.rse forT- Cell Stimulation by Allogeneic Epidermal 
Cells; E pidermal L y mphocyte Reaction 
When epidermal cells fTom BALB/c mice were cocultured 
with T cells fTom C57Bl/6 mice, pro liferation of T cells (as 
determined by uptake of [3H]thymidine) peaked on day 5 (Fig 
1). This T-cell proliferation was significantly less when epider-
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FIG 1. Time course for T-cell stimulation by allogeneic epidermal 
cells; epidermal lymphocyte reaction (ELR). Varying numbers of epi-
dermal cells (2 X 10'', 1 X 10'', or 0.5 X LO") from UV-LreaLed or non; 
UV -treated BALB/ c mice were cocul tured for 1-14 days with 2 x 10·· 
T ce lls from C57Bl / 6 mice. ["H]TdR was added for the last 16 h of 
cul t ure. Bars represent mean cpm ["HlTdR incorporation ± SE. T 
cells without stimulator cells were used as background counts (firs / bar 
on each clay). From day 0 to day 2 and from day 8 to day 14 no 
significant stimulation was seen (data not included). 
TABLE I. Asses-<men.l of E TAF activity from epiclemw.l cells from 
UV- or non- UV-irradiated mice 
cprn ["HlTdR incorporation 
Source of D ilu tion'' by C3H/ HeJ thyrnocyt.es 
·upernata nt" 
Experiment I Experiment. 2 
UV-EC 1:4 1,856 ± 30 !'' 2,228 ± 323'' 
UV-EC 1:8 948 ± 488 942 ± 70 
UV-EC 1:16 701 ± 214 584 ± 16 
UV-EC 1:32 714 ± 250 518 ± 41 
EC 1:4 6,578 ± 986 6,070 ± 736 
EC 1:8 3,214 ± 578 2,373 ± 572 
EC 1:16 1,008 ± 211 1,097 ± 117 
EC 1:32 648 ± 325 734 ± 140 
No supernatant 576 ± 211 689 ± 89 
added 
" S upernatant prepared by cul turing 2 X 10" BALB/ c epidermal 
cells/ml from UV-treated mice (UV-EC) or from non-UV-treated mice 
(EC) fo r 3 clays. The supernatant was dialyzed and tested for ETAF 
activ ity by its ability to augment PHA-inclucecl thymocyte proliferation. 
" F inal dilu tion of ETAF in the culture. 
,. c pm ± SE. 
mal cells t-i·om UV -treated mice wer e used as stimulator cells. 
Maximum T -ceU prolifer a tion was gener ally seen when 0.5 X 
105 or 1 X 10'' epidermal cells we re used as stimulator cells. 
Assessment of ETAF Activity from UV- and Non-UV-
Treated Epidermal Cells 
When epide rmal cells from UV -treated a nimals were cultured 
and t h e supernatant was tested for E TAF activity, t here was 
s ignificantly less activ ity (p < .05) th an t hat detected in supe r-
natants from cells fro m non-UV-treated mice (Ta ble I) . 
Reversal of UV- Inhibition ofT-Cell Stimulation with ETAF 
W h en fractions of Sephadex G-50 purified ETAF (final dilu-
tio n 1:4) wer e added to epidermal cells from UV-treated mice 
and t h ese ce lls cocultured with T cells, s ignifica n t r estoration 
ofT -cell stimulation was seen (p < .01) . L it tle or no increase in 
T -cell stimulation was seen wh en ETAF was a dded to t he· 
cul tures conta ining epide rma l cells from non-UV-treated mice 
(Table II) . 
Effect of ETAF on Epidermal Lymphocyte Cultures Using 
Syngeneic R esponder and Stimulator Cells 
As s hown in T a ble III using a 5-day cul ture, no s ignifican t 
a u tologous epide rma l lymphocyte reaction was seen with or 
wit h o u t t he a ddition of ETAF. Ther e was, however, a signifi-
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can t allogene ic epider mal lymph ocyte reaction w hich was in -
hibi ted by UVR a nd partially restored with ETAF. 
Requirement for Epidermal Langerhans Cells in the 
Induction of A llogeneic T-Cell Stimulation 
When BALB/c epidermal cells were tr eated with anti-Ia 
a n tiserum (A.TH a nti A.TL) plus complement, and t h ese Lan-
gerhans cell-depleted epidermal cells were used as stimulator 
cells, there was no significan t T-cell stimulation. In addit ion, 
when ET AF was a dded to these Langerha ns cell-depleted cul-
tures, t here was no incr ease in T-cell proliferation (Table IV). 
T his implies t hat Langerha ns cells al'e needed fol' T-cell stim-
ulation a nd that ETAF alone will not r estore stimulation. 
E ffect of UVR on Epidermal Cell Viability 
Table V sh ows t hat via bili ty of epidermal cells from UV-
treated a nima ls is not s ignificantly different from epidermal 
TA BLE II. U\1 alteration in the ability of epiderm al cells to act as 
stimulator cells for allogeneic T cells: restoration with ETAF 
timulalor cells" 
2 x 10'' EC (BALB/ c) 
1 x 10'' EC (BALB/c) 
0.5 x 10'' EC (BALB/ c) 
2 x 10'' UV-EC (BALB/ c) 
1 x LO'' UV-EC (BALB/ c) 
0.5 x 10'' UV-EC (BALB/ c) 
No stimulator ce lls 
cpm ["H]T dR incorporation 
by responde r T ce lls 
Without ETAJ? 
6,618 ± 727'' 
9,84 1 ± 682 
7,162 ± 1,197 
3,022 ± 389 
3,334 ± 1, !l 7 
3,450 ± 580 
1,178 ± 256 
With ETAF'' 
5,516 ± 675'' 
8,895 ± 275 
7,888 ± 596 
4,430 ± 158 
6,041 ± 193 
6,004 ± 259 
1,050 ± 388 
1,050 ± 388 
"Epidermal ce ll were prepared from non-UV-treat.ed BALB/c mice 
(EC) or from UV-treated mice (UV-EC). 
" ETAF prepared from column pmifiecl supernatant from cu ltured 
BALB/ c epidermal cells and added to the cul tures to make a final 
dilution of 1:4. 
·· cpm ± SE ["H]TdR incorporation by T cells from C57Bl/6 mice 
cocul turecl 5 days with UV-EC, wi th EC, or alone. 
TABLE III. Epidermal cells stimulate allogeneic but not syngeneic T 
cells 
. tim ula lor cells" 
2 x 10'' EC (BALB/c) 
1 x 10" EC (BALB/ c) 
0.5 x LO'' EC (BALB/ c) 
2 x 10'' UV-EC (BALB/ c) 
1 x l O'' UV-EC (BALB/c) 
0.5 x 10'' UV-EC (BALB/ c) 
2 x 10" EC (B6) 
1 X 10" EC (B6) 
0.5 x 10'' EC (B6) 
2 x 10'' UV-EC (B6) 
1 x 10" UV-EC (B6) 
0.5 x 10'' UV-EC (B6) 
cp m [ "H]Td R inco rporation 
by respo nder T ce lls 
from C57BI/ 6 mice 
Wi thout ETAJ? With ETAF" 
4,147 ± 495'' 4,019 ± 219'" 
5,235 ± 580 4,718 ± 50.1 
2,821 ± 383 4, 145 ± 510 
1,563 ± 72 1 3,048 ± 309 
1,.1 36 ± 374 3,856 ± 513 
1,287 ± 518 2,013 ± 259 
1,102 ± 484 918 ± 79 
1,236 ± 532 1,121 ± 721 
908 ± 211 856 ± 256 
899 ± 194 799 ± 41a 
1,118 ± 316 1,209 ± 425 
868 ± 306 999 ± 187 
"Epidermal cells were prepared from noninadiated BALB/ c mice 
[EC(BALB/ c)], non-UV-irradiated C57Bl/6 mice [EC(B6)], or from 
UV-irradiatecl BALB/c or C57Bl/6 mice [UV-EC(BALB/ c) and UV-
EC(B6)]. 
"ETAF prepared from column purified supernatant from cultured 
BALB/c epidermal cells and added to the cuHures Lo make a fi na l 
di lu tion of 1:4 . 
·· cpm ± SE ["HlTdR incorporation by T ce lls from C57Bl/6 mice 
cocul Lured 5 days wit.h UV-EC, with EC, or alone. 
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TABLE IV. Requirement for epiderm.a.l Lan.gerlwn.s cells for 
stimulation of allogeneic T cells 
Stimulator cells" 
2 x 10'' EC (NMS + C') 
I x 10'' EC (NMS + C' ) 
0.5 x 10" EC (NMS + C') 
2 x 10" EC (ala + C' ) 
1 x 105 EC (a la + C') 
0.5 x 10'' EC (a la + C' ) 
None 
cpm ["HJT d R inco rpora t ion 
by responder T cells 
Withou t ETAF 
3,702 + 286'" 
6,908 + 1,666 
7,751 + 329 
1,714 + 500 
1,226 +53 
2,130 + 714 
1,178 + 256 
With E T AF" 
4,078 + 595'" 
7,001 + 286 
6,54 3 + 71.1 
1,528 + 758 
1,311 + 256 
2,005 + 819 
1,050 + 388 
"Stimulato r ce lls were BALB/c epiderma l cells treated with normal 
mouse serum plus complement EC (NMS + C') or anti-Ia ant iserum 
plus complement EC (a la + C') . 
1
' ETAF prepared fro m column puri fied supernatant from cul tured 
BALB/ c epidermal ce lls and added to the cul tures to make a fi nal 
di lu tion of 1:4. 
< cpm + SE ["HlTdR incorporation by T ce lls from C57BI/6 mice 
cocul l ured fo r 5 days with a la plus complement-treated BALB/ c epi-
dermal cells. The above groups were cul tured with or without a 25% 
(final concentra tion) solu tion of column purified ETAF. 
TABLE V . Viability of cultured epidermal cells a.n.d Langerh.ans 
cells a. fter UV irradiation. 
EC 
UV-EC 
Day 0 
89/ 1.7 
85/ 1.8 
Percentage viab le epidermal cells/perce ntage 
viable cells that were Ia posit ive" 
Day I 
64 / 1.9 
57/ 1.5 
Day 2 
34/ 1.0 
39/ 1.0 
Day 3 
26/ 0.6 
31/ 0.7 
Day 4 
24 / 0.2 
17/ 0.3 
Day 5 
19/ 0. 1 
15/0.09 
" Epidermal cells from UV -treated or non-UV -treated mice were 
cul tured fo r 5 days. Percentage of viable epidermal ce lls and the 
percentage of viab le epidermal cells tha t were Ia positive were deter-
mined daily. Overa ll viability was assessed by trypan blue dye exclusion 
and the pe(centage of viable cells that were Ia posit ive (Langerhans 
ce lls) was assessed by s imul taneous fluorescent Ia sta ining and ethidium 
bromide s ta ining; approx imate ly 300 cells were counted in each group. 
cells from non-UV-treated mice. In addi tion, by using a double 
flu orescent staining technique with ant i-Ia ant iserum and etrud-
ium bromide to specifically look at via ble Langerhans cells (i.e., 
!a-stained cells that excluded ethidium bromide), it was found 
that there was no difference in Langerhans cell viability be-
tween t he 2 groups. In addi tion, there was no alteration in 
surface Ia as detected by indirect immunofluorescence. 
DISCUSSION 
!a-bearing macrophages are considered to be the major stim-
ulatory cells in the mixed lymphocyte reaction [1- 7]. S teinman 
and Nussenzweig have shown tha t certain murine splenic den-
dJ·it ic cells ar e also capable of stimula ting a mixed lymphocyte 
reaction [28). Human epidermal cells have also been shown to 
cause stimulation of allogeneic lymphocytes [29,30]. Using mu-
rine epidermal cells, we have shown that epidermal cells ar e 
capable of acting as stimulator cells for allogeneic T cells 
(epidermal lymphocyte reaction) , tha t the stimulatory cell is 
the Langerhans cell , and that UVR is capable of abrogating this 
reaction. The latter finding is in keeping with in vi tro studies of 
Lafferty a nd Woolnough [12), Lindahl-Kiesling and Safwenberg 
[31], and R ollinghoff and Wagner [32], who have shown that 
UVR t reatment of stimulator cells alters alloantigen stimula-
t ion. 
UVR has profound effects on the immune system both in 
vivo and in vi t ro. UV-treated mice have a redu ced capacity to 
reject UV-induced tumors [33,34] and do not show a normal 
graft-vs.-host reaction when allogeneic lymphocytes are in-
jected into their foot pads [35]. UVR is a lso capable of sup-
pressing allergic contact sensitiza tion [26,36,37]. The mecha-
Vo l. 80, N o. 6 
nism behind these in vit ro or in vivo UVR alterations in immune 
function has been the subject of considerable investigat ion. 
Some studies have suggested that UVR may a ffect IL-l pro-
du ction [12,17,38]. Lafferty and Woolnough [1 2] postulated that 
the UV -induced defect in alJ oant igen presentation was related 
to the inabili ty of UV-treated cells to provide a soluble "co-
stimulator" fun ction , termed "second signa l." lt has been pos-
tulated that interleukin 1 plays an integra l rol e in T -ceU acti-
vation responses and may provide this second signal [16]. 
The data presented here are in keeping with the a bove 
findings. In paTticular, we have shown that UV treatment of 
epidermal cells reduces theiT abili ty to present alloant igens 
without affecting cell viabili ty. Furthermore, this defect is as-
sociated with a decrease in the producti on of the soluble epi-
dermal cell product ETAF. In addi t ion , thi UV -induced defect 
can be partia lly reversed with the addition of exogenous ETAF. 
I t is not clear whether UVR affects ETAF alone or whether 
there is also a UV -induced a lteration of Langerhans cells 
whereby their stimulato ry abi.li ty is affected. It is possible that 
l a antigens on the Langerha ns cells ar e funcliona lly altered a nd 
yet still detectable by immunotluorescence sta ining. We would 
favor t he hypothesis tha t UVR, in addi t ion to a ltering ETAF 
production, alters Langerhans cell alJoant igen-present ing fun c-
tion to some degree. The studies of Germain [17], Weinberger 
et al [38), and the recent studies of Jakway et al [39) using in 
vi tro UVR would support the hypothesis t hat UVR alters 
antigen processing as well as IL-l production. Germain showed 
tha t if ant igen-presenting cells were UV -treated before pulsing 
with ant igen, these cells fa iled to support an t igen-specific T-cell 
proliferation even in the presence of P MA, a potent stimulator 
of IL-l production. In a similaT line of investigation, Weinberger 
et al [38) demonstrated that when splenic adherent cells were 
UV-treated prior to pulsing with H-2K k ant igen, they were 
incapable of inducing cytotoxic T cells, bu t if they were UV-
treated after pulsing with H-2K k antigen, cytotoxic T cells could 
be restored in the presence of PMA. Simila r findings were 
shown by J akway et al [39], us ing an in vi tro guinea pig antigen 
presenta tion system and guinea pig IL-l. They showed that 
antigen presenta tion could not be restored wi th IL-l if macro-
phages were UV -treated prior to pulsing wi th ant igen, bu t 
antigen presentation could be partially restored wi th IL-l if 
macrophages were treated after pulsing wi th a ntigen. These 
findings suggest that UVR may interfere with ant igen process-
ing as well as IL-l production. Om system is, however, not 
directly analogous to the above system s ince we are irradiating 
the mice in vivo, then preparing epidermal cells from these 
animals, and using these epiderma l cells as stimulator cells for 
a llogeneic T cells. Presumably, om pretreatment with UVH 
only par tially inactivates the stimulato r cells a nd , t herefore, 
restora tion is possible. When stimu la tor cells are inactivated 
with ant i-Ia ant iserum and complement, no restoration is 
achieved. 
UV altera tion of alloantigen presentation by epidermal cells 
may prov ide a unique opport unity to dissect out the various 
signals necessary for alloantigen presentation. In the conven-
tional systems of antigen presentation by macrophages, mac-
rophages are the somce of both signal 1 and signal 2. Like 
macrophages, Langerhans cells are the source of processed 
antigen (signal 1), but it is unknown whether Langerhans cells 
produce any ETAF (signal 2) [21]. One source of the second 
signal is clearly the kera tinocy te [21,22). Therefore, within the 
epidermis, one cell type, the Langerhans cell , provides the first 
signal, i.e., the formation of the Ia-a lloant ige n complex, but may 
not provide the nonspecific second signal . The nonspecific 
second signal can be provided by the keratinocyte, which is 
incapable of antigen presenta tion . The epidermis thus has 2 
distinct ceU popu la tions which may provide separ a te but nec-
essary signals for a ntigen presenta tion . Keratinocyte cell lines 
ar e available, and hopefully in the near future Langerhans cell 
lines may be derived. These distinctive ceU populations thus 
may provide the potential to dissect out the vru·ious signals 
necessary for antigen presenta tion . 
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